Back to Stocks
Stock detail
Johnson & Johnson
JNJSTOCKS | US | NYSE | Healthcare | Drug Manufacturers - General
Profile snapshotUSD 266.7Market cap USD 642.8B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BearishMA 8/21 Crossover15M28 Jul 26, 15:4577
BullishOrder Block Setup15M28 Jul 26, 15:4580
BullishOrder Block Setup4H28 Jul 26, 13:3062
BullishOliver Kell Momentum Setup4H28 Jul 26, 13:3075
BullishMinervini Trend Template4H28 Jul 26, 13:3080
BullishMA 8/21 Crossover4H28 Jul 26, 13:3089
BullishOliver Kell Momentum Setup1D28 Jul 26, 00:0070
BullishMA 8/21 Crossover1D28 Jul 26, 00:0079
BullishMinervini Trend Template1D28 Jul 26, 00:0086
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 82.6B+0.6%USD 78.7B-4.7%USD 80B+1.6%USD 85.2B+6.5%USD 88.8B+4.3%USD 94.2B+6.0%
Net incomeUSD 14.7B-2.7%USD 20.9B+41.9%USD 17.9B-14.1%USD 35.2B+95.9%USD 14.1B-60.0%USD 26.8B+90.6%
Net profit margin17.8%-3.3%26.5%+48.8%22.4%-15.4%41.3%+84.0%15.8%-61.6%28.5%+79.7%
EPS5.59-2.6%7.93+41.9%6.83-13.9%13.88+103.2%5.84-57.9%11.03+88.9%
Quarterly
Quarterly fundamentals
Q2 2026 vs same quarter previous year
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q2 2026
Total revenueUSD 23.7B+5.8%USD 24B+6.8%USD 24.6B+9.1%USD 24.1B+9.9%USD 25.3B+6.6%USD 25.3B+6.6%
Net incomeUSD 5.5B+18.2%USD 5.2B+91.2%USD 5.1B+49.1%USD 5.2B-52.4%USD 5.5B-0.1%USD 5.5B-0.1%
Net profit margin23.3%+11.7%21.5%+79.1%20.8%+36.7%21.8%-56.7%21.9%-6.2%21.9%-6.2%
EPS2.29+17.4%2.14+91.1%2.1+46.9%2.14-53.2%2.27-0.9%2.27-0.9%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30


